NBSE - NeuBase Therapeutics reports Q1 results May, 13 2021 05:12 PM NeuBase Therapeutics Inc. NeuBase Therapeutics (NBSE): Q1 GAAP EPS of -$0.24.The Company had cash and cash equivalents of approximately $24.2 million.Press Release For further details see: NeuBase Therapeutics reports Q1 results